PSAMP
ORIAU

P. Schoenfeld Asset Management (PSAM)’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio ORIAU Stock Details ORIAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500,000
Closed -$4.93M – 496
2021
Q4 		$4.93M Hold
500,000
– – 0.24% 95
2021
Q3 		$4.95M Hold
500,000
– – 0.31% 74
2021
Q2 		$5.03M Buy
+500,000
New +$5.04M 0.29% 70

Other funds holding ORIAU

JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s ORIAU Position: Q1 2022 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q1 2022, closing a stake of 500,000 shares — an estimated $4.93M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in ORIAU in Q2 2021 and held it in 3 quarters. The position peaked at $5.03M in Q2 2021. 14 funds tracked by Wall St. Rank hold ORIAU as of Q1 2022.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Orion Biotech Opportunities Corp. Units position as of Q1 2022 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 500,000 Orion Biotech Opportunities Corp. Units shares in Q1 2022, an estimated $4.93M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 3 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Orion Biotech Opportunities Corp. Units position peaked at $5.03M in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q1 2022.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q1 2022, filed 13 May 2022.